A new drug compound could combat tough-to-treat melanoma
Melanoma is commonly caused by the damaging effects of ultraviolet light—from sources like sunlight and tanning beds—on the DNA of skin cells. This UV damage can activate genes that encourage precancerous cells to further mutate into full-blown skin cancer. At the same time, UV damage can turn off other genes that would normally prevent tumor growth. With enough wrongly flipped switches, cancer can flourish. And melanoma is certainly flourishing. This year alone, 96,480 new instances of melanoma will be diagnosed in the United States and 7,230 Americans will die from the disease.
With so many people affected by melanoma, scientists are on the hunt for better ways to screen for melanoma risk and treat the most lethal types of skin cancer. One particularly voracious type of melanoma, caused by mutation of a gene called NRAS (which instructs cells to produce a protein of the same name, NRAS), drives 25 percent of skin cancers.
“There are immunotherapies and targeted therapies that have shown huge improvements for patients with melanoma,” said Rutao Cui, a Boston University School of Medicine professor of pharmacology and dermatology. “However, for patients with NRAS mutations, they don’t have very useful or very effective treatment strategies.”
Now, an international research team led by Cui has discovered a new way to stop the progression of melanoma by NRAS mutations with the flip of a genetic switch. Their findings were published January 31, 2019, in Cell.
Inside our bodies, proteins like NRAS play the role of dominoes, interacting with one another to switch other important gene activities on or off. The researchers set out in search of a way to interrupt the process in which mutated NRAS can instigate the growth of skin cancer. Since targeting the NRAS gene—just one of several dominoes in this type of skin cancer pathway—has proven to be so difficult, the researchers were determined to find another approach.
For NRAS to trigger cancer development, it first needs to be activated by another protein in the body. Until now, it’s been unknown exactly which protein is responsible for activating NRAS. But after testing the effect of several different proteins on the activity of NRAS, the team zeroed in on a likely culprit, a protein by the name of STK19.
STK19 is not a newly discovered protein in its own right, but its purpose has not been known until now. Cui’s team found that STK19 appears to work as an “on” switch for NRAS—activating production of NRAS proteins which, in turn, trigger the toppling of several other genetic dominoes downstream.
The researchers also found that, unlike NRAS, they could disable the STK19 gene and greatly diminish its ability to set the skin cancer sequence in motion.
Together, the team designed a new drug compound to shut down the effect of STK19 on NRAS. Then, testing its effect on skin cells cultured in petri dishes and in animal models, they proved that their compound can block NRAS activation and prevent melanoma from developing.
Cui says that this result is exciting not just for melanoma, but for other cancers as well. While the relationship between STK19 and NRAS may be particular to skin cancer, the approaches the team used to identify and block key activating proteins can be applied to find new treatments for similarly difficult-to-cure cancers.
Now the research team is looking to take their research to clinical trials to test out the STK19 inhibitor in humans, and hopefully, someday make it available as a targeted therapy to combat NRAS-driven melanomas.
In the meantime, Cui says that much work still needs to be done to not only create better and more precise treatments for patients suffering with melanoma, but also to alert vulnerable populations about the risk factors associated with the cancer.
“We need more monitoring for early diagnosis and full-body examinations for problematic spots,” says Cui, “and more proactive strategies for patients [at the highest risk of developing melanoma] to prevent cancer progression and metastasis.”
Learn more: Shutting Down Skin Cancer
The Latest on: Skin cancer
via Google News
The Latest on: Skin cancer
- Spotting the Signs of Deadly Melanoma Skin Cancerson August 22, 2021 at 6:00 am
Regular skin checks to look for signs of melanoma could save your life. Self-exams for the deadliest type of skin cancer should be done at least once a month in a well-lit room in front of a ...
- Memoir offers intimate portrayal of one woman’s journey through skin canceron August 22, 2021 at 1:00 am
In 'Skin,' Maine writer Kate Kennedy tackles her diagnosis and treatment with a purposeful – and defiant – precision.
- ESPN analyst Dick Vitale has melanoma skin cancer removed: 'I was a little shook up'on August 21, 2021 at 2:46 pm
ESPN college basketball analyst Dick Vitale had a patch of melanoma, a form of skin cancer, removed from just above his nose.
- Legendary ESPN Broadcaster Dick Vitale Reveals Skin Cancer Diagnosis, Patient With Cancer Receives COVID-19 Booster Shot and Moreon August 20, 2021 at 8:00 am
From Dick Vitale’s early melanoma cancer detection to the authorization of COVID-19 vaccine booster shots for patients with cancer, here’s what’s happening in the cancer landscape this week.
- Melanoma Skin Cancer Diagnostic Testingon August 20, 2021 at 6:12 am
The global Melanoma Skin Cancer Diagnostic Testing Market was worth xx billion in 2020, and it is predicted to increase at a CAGR of xx% from 2021 to 2027. The spread of the COVID-19 has encouraged ...
- AI Can Help Diagnose Skin Cancer – But Only on White Skinon August 19, 2021 at 8:56 pm
A new image-based AI tool can suggest clinical next steps for melanoma, but for darker skinned patients, equal outcomes are lacking.
- What are skin cancer symptoms and signs and what does the disease look like?on August 18, 2021 at 4:01 am
THERE are hundreds of different types of cancers and it remains one of the biggest killers. The most deadly form is lung cancer, followed by bowel, prostate and then breast. These four cancers ...
- I got skin cancer TWICE in one year – I was a sunworshipper using only low factor sun creams & going on sunbeds weeklyon August 14, 2021 at 2:05 pm
A MUM who got skin cancer twice in one year after using low factor sun creams and going on sunbeds WEEKLY wants to warn others of the dangers of them. Lisa Costello, 39, from Colchester, ...
- Skin Cancer Risks in People of Coloron August 12, 2021 at 12:32 pm
People of color are at lower odds for melanoma, but also face lower survival rates and risk of a rare condition called acral lentiginous melanoma.
- One key question can help spot skin canceron August 11, 2021 at 8:58 am
(HealthDay)—When a suspicious skin lesion sends you scurrying to a dermatologist, asking for a full-body skin check could save your life.
via Bing News